NEFL and Brain atrophy: Given that this study also found a strong correlation between the occurrence of ARIAs and brain atrophy (involving both grey and white matter), and considering a different report that showed that whole-brain atrophy induced by donanemab [94] was associated with increases in plasma NfL protein, it is likely that the observed brain volume loss reflects neurodegeneration.